Fluorine-18 Prostate-Specific Membrane Antigen–1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer

202432 citationsJournal Articlehybrid Open Access

Authors

Nikhile Mookerji · University of Alberta

Tyler Pfanner · University of Alberta

Amaris Hui · University of Alberta

Guocheng Huang · University of Alberta

Patrick Albers · University of Alberta

Rohan Mittal · University of Alberta

Stacey Broomfield ·

Abstract

In this phase 2 prospective validating paired cohort study, 18F-PSMA-1007 PET/CT was superior to MRI for the locoregional staging of prostate cancer. These findings support PSMA PET in the preoperative workflow of intermediate-risk and high-risk tumors.

Topics & Keywords

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Radiomics and Machine Learning in Medical Imaging

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Oncology

Volume 10, Issue 8, pp. 1097-1097

DOI: 10.1001/jamaoncol.2024.3196

Field-Weighted Citation Impact: 13.29